Photo of a patient and health professional talking in a treatment room.
Health professionals

Last reviewed: 24 October 2024

Cervical screening

Healthcare professionals play a vital role in supporting people to make informed decisions about participating in cervical screening.

Last reviewed: 24 October 2024


Overview

Cervical screening is available to anyone with a cervix between the ages of 25 to 64 in the UK. The cervical screening test can identify people with HPV infection and facilitates the identification of changes to cells in the cervix which could develop into cancer if left untreated. 

Cervical screening saves at least 2,000 lives each year in the UK.

Now that human papillomavirus (HPV) primary testing and vaccination have been implemented across the UK, we can expect to see cervical cancer incidence decrease even further, with more lives predicted to be saved.

There are several factors which affect eligibility for cervical screening as well as barriers to access which disproportionately affect different demographics. We’ve updated our Cervical screening good practice guide to help health professionals provide the right information to patients, so they can make an informed choice about participation. 

Download our cervical good practice guide(PDF, 1.78 MB)

Insights

Illustration of a magnifying glass.

Cervical cancer prevention: HPV vaccination and screening

Read about primary human papillomavirus (HPV) testing and cervical screening coverage.

Illustration using three icons of people, representing a group.

Encouraging informed participation

The latest evidence on barriers and resources to support informed choices.

Illustration of a shield with tick symbol.

Future optimisation of cervical screening

Covers extending screening intervals, self-sampling and wider quality improvements.

Information for the public

Find out what cervical screening is, who’s eligible and how to get tested.

Read our public cervical screening information

References

  1. Arrow return up icon

    Landy, R., Pesola, F., Castañón, A. et al. Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study. Br J Cancer 115, 1140–1146 (2016). https://doi.org/10.1038/bjc.2016.290

  2. Arrow return up icon

    Bains I, Choi YH, Soldan K, et al Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in England International Journal of Gynecologic Cancer 2019;29:669-675. https://ijgc.bmj.com/content/29/4/669 


Contact us

You can contact our Strategic Evidence team if you have any questions.

Email us

Stay connected

Follow Cancer Research UK Health Professionals

Read news, updates and opinion, posted weekly.

Sign up for our Health Professionals newsletters

Stay up-to-date with the latest cancer research information.